The TACT Trial – Presentation by PI* Dr Gervasio Lamas & the movie Unleaded

Posted by Dr Dan Carter

I was fortunate to be present at a talk given by Dr Gervasio Lamas, the principle investigator *(PI) for the TACT (Trial to Assess Chelation Therapy) trial; he gave a good overview of the trial design and results at the ACAM spring meeting, held May 31-June 2, 2013. Dr. Lamas is the Chairman of Medicine at Mount Sinai Medical Center and Chief of the Columbia University Division of Cardiology at Mount Sinai Medical Center. This LINK http://www.miami-cardiology.com/dr-gervasio-lamas.php  gives you access to his complete bio. I got the sense that he was very courageous to serve as study chair for the TACT trail, as he has received his fair share of grief from mainstream medicine due to what has been termed the “inconvenient evidence” that chelation therapy is both safe and effective. Ref: [http://www.forbes.com/sites/harlankrumholz/2013/03/27/chelation-therapy-what-to-do-with-inconvenient-evidence/]

Dr Lamas is not the only person being denigrated for his willingness to be associated with the trial, the editors of  JAMA, the Journal of the American Medical Association have received a lot of criticism for publishing the trial results in the journal. 

A lot of the criticism bordering on fanaticism is being leveled at the trial, where only specific dogma that is aligned with certain factions’ beliefs are acceptable; this is a real problem in today’s medical community. Before the trial, the critics argued that EDTA chelation was unproven as no trials had been done, and now that the first RPCCT (Randomized placebo controlled clinical trial) has been completed, it is still not sufficient. Some physicians within mainstream medicine go frankly apoplectic if they are presented with ideas/trial results that are outside their narrow paradigms, to wit: David Gorski, a surgical oncologist, in an assault on TACT, JAMA, and Arlen Krumholz (of Forbes Magazine), writes “that JAMA is every bit as guilty as The Lancet was in 1998 when it published Andrew Wakefield’s anti-vaccine nonsense…. If published at all, TACT should have been published in some crappy, bottom-feeding journal, because that’s all that it deserves.” So it would seem that vitriolic reactive fervor trumps scientific reason whenever it’s not in alignment with one’s world view.

Dr Lamas went over the Study Design in some detail. Ref. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243954/#!po=31.2500 One important element he mentioned, and that is brought out in the movie Unleaded as well (see review below), is that the patients enrolled in the trial were maintained on ALL conventional treatments that were prescribed before the trial started. So no (conventional) treatments were taken away; the only change was the addition of the TACT protocol of either active treatment or placebo. One argument that critics have mentioned, is that the trial was not ethical – if they actually read the full text article, they will find that this trial was one of the most ethical performed in recent history. The trial was halted for a period of time, while concerns about the informed consent were addressed and corrected – this was the area where complaints about unethical  conduct were broached, and once this was corrected, the trial was continued.  The results speak for themselves (see previous blog post, July 13, 2013). Trials administered by pharmaceutical companies are much more likely to see problems with ethical conduct, especially when those trials take place in developing countries. Ref. [http://somo.nl/publications-en/Publication_2534]

Sidebar

Bias in medicine is common, and old ideas die hard. It seems as though critics delight in negativity toward any subject they do not agree with. Even when bias or outright fabrications are found in clinical research, it is difficult to correct the misconceptions that have already been accepted as truth. This article points out many of the issues faced by medicine: http://www.theatlantic.com/magazine/archive/2010/11/lies-damned-lies-and-medical-science/308269/ . Another article speaks to some of the questionable teaching methods that shape the thinking of most future physicians: [Haizlip J, et al. Perspective: the negativity bias, medical education, and the cuture of academic medicine: why culture change is hard. Acad Med. 2012 Sep;87(9):1205-9. PMID 22836850]

 

 

Unleaded – The movie [Movie website & trailer: http://www.elemental-films.com/]

Note: My review is 3 months after watching the movie, so the memories may be selective and incomplete; my apologies, as the movie is well worth watching. Unleaded is presented as interviews with two of the clinical investigators for the trial, Roy Heilbron, MD and Angelique Hart, MD, as well as interviews with several trial participants. From the Elemental Films website: “On Nov. 4, 2012, Dr. Gervasio Lamas, the director of the TACT study presented the stunning results of the 10 year study that involved over 130 clinics and 1,700 patients at the annual American Heart Association’s (AHA) 2012 Scientific Sessions. Later that day, Elliott Antman, MD, Director of the AHA, announced that there was not enough information to recommend Chelation Therapy until more studies were done, although TACT was designed to be the definitive 10 year study. Normally published the same day as the presentations, the NIH TACT statistical results were not published by the Journal of the American Medicine Association for an unprecedented 5 months, until March 27, 2013, at which time they were either not reported or obscured within any articles by mainstream media.” Dr Heilbron brought out several rather amazing observations about the AHA meeting…

  • The significance of the TACT trial results were much more striking than the degree of significance of most drug trials, and yet this was dismissed by critics
  • The dismissive statement by Dr Antman was carried by all of the major news media, but the results of the trial were not
  • The JAMA publication of statistical results was delayed, because the editors were justifiably worried about political (the politics of medicine) fallout

The trial participant interviews were very interesting as well, and since the trial results did show significance, they cannot be dismissed as anecdote.

 

Scroll to Top
Vertisis Custom Pharmacy

Vertisis Custom Pharmacy

Vertisis is one of the most unique sterile-injectable compounding pharmacies in the United States. Our focus is on going “above and beyond” traditional compounding pharmacies by raising the standards of 503A compounding pharmacies to include exceptional products, unique delivery, advanced education, and an amazing relationship with health care providers with a seamless delivery of care. Vertisis originates from over 20 years of clinical practice in custom compounded pharmaceutical agents and over 100 years of combined compounding pharmacy experience with clinical usage of the latest technologies. We have intimate knowledge of hundreds of thousands of custom compounded pharmaceutical treatments with a team of knowledgeable pharmacists to help answer your questions.

Sign up to receive seminar news and updates!

TransLite LLC

345 Commerce Green Blvd.
Sugar Land, TX 77478

TransLite LLC is a small high tech company comprising dedicated people who design, manufacture and sell medical devices that can help reduce the pain and trauma to patients during venous access and treatment of varicose veins.
Our mission is
• To design innovative medical products that help mankind
• Produce highest quality products at affordable prices
• Provide excellent service and support to our customers
We are accomplishing our mission by providing Veinlites® to healthcare professionals all over the world. Since 1999, over 40,000 medical professionals have come to rely on Veinlite® vein finders for simple and consistent one-stick vein access. If failed IV attempts are a daily occurrence among your team, don’t get frustrated…get Veinlite®!

Phone: (281) 240-3111
Fax: (281) 240-3122

With Veinlite® products, you can locate and access veins within seconds – even in the most difficult patients whether due to their age, weight, or skin tone.
Please visit www.veinlite.com or contact us for more information at info@veinlite.com or 281-240-3111.

McGuff Family of Companies

Legacy Corporate Contributor
2921 W. MacArthur Blvd., Suite 142
Santa Ana, CA 92704

McGuff Company Inc. is a wholesale distributor of over 5,000 competitively prices pharmaceuticals, IV related products, physician office & exam room supplies and an extensive oral nutritional line to support your patient’s treatments. Our experienced customer service staff are experts at finding hard-to-find products. We maintain close relations with both large and small manufacturers of quality products to assure we will meet all of your needs. Competitive prices for over 35 years!

Verified-Accredited Wholesale Distributor (VAWD)
Phone (800) 854-7220 Toll Free
Fax (714) 540-5614 Toll Free Fax

McGuff Compounding Pharmacy Services specialty pharmacy compounding all dosage forms – preservative-free injections, amino acids, natural hormones and custom formulations all at competitive prices. Injectables are tested for particulates, sterility and endotoxins.

Accredited by the Pharmacy Compounding Accreditation Board (PCAB) &
Independently certified as ISO 9001-2008
Phone (877) 444-1133 Toll Free
Fax (877) 444-1155 Toll Free Fax

SterileDrugs.com

P.O. Box 308
Ada, MI 49301-0308
Toll-Free: (844) 733-7847
info@steriledrugs.com

SterileDrugs.com is committed to helping medical providers and practices overcome the challenges of acquiring the very best custom and non-custom medications. By contracting with multiple FDA-Registered Outsourcing Facilities (503B pharmacies), our goal is to be your source, resource, and solution for the highest quality medications at the most competitive prices.

About SterileDrugs.com
SterileDrugs.com partners with 503B pharmacies that specialize in manufacturing medications for IV Nutritional Therapy, Hormone Replacement Therapy & Weight Loss. Our pharmacy partners are held to the highest quality standards by the FDA and comply with USP 795, 797 & cGMP guidelines. For a complete list of the medications we offer, as well as pricing, please contact us at: www.steriledrugs.com or 844-73DRUGS

Doctor’s Data, Inc.

3755 lllinois Avenue.
St. Charles, IL 60174 – 2420 USA
US and Canada (800) 323-2784

Doctor’s Data, Inc. has provided innovative specialty testing to healthcare practitioners around the world from our advanced, CLIA-licensed clinical laboratory since 1972. Choose DDI to help you assess and treat heavy metal burden, nutritional deficiencies, gastrointestinal function, hormone and HPA/adrenal function status, cardiovascular risk, liver and metabolic abnormalities, and more.

Simply O3

We help you get started with ozone therapy in your clinic – Grow your income and improve patient outcomes.  Download the DEFINITIVE Guide to Getting Started with Ozone Therapy by going to www.DrsOzone.com/Guide.  Full training and support available  Equipment has a 6 month money back guarantee and is easy to use.  Go download your FREE guide to getting started now at www.drsozone.com/guide.

Merit Pharmaceutical

2611 N. San Fernando Road
Los Angeles, CA 90065
Phone (800) 421-9657 Toll Free US & Canada
Fax (323) 227-4833
solutions@meritpharm.com

Offering IV infusion from Merit? Getting your med/surg/pharma from us? Your colleagues are and they have higher profits. Merit supplies Anti Aging/Aesthetic/Integrative practitioners better prices on the products you use. Call us and learn why successful clinics partner with Merit. IV Therapy Nutrition/Hydration, Weight Loss, Hormones, IV solutions, PRP products, exam/surgical supplies and more. Merit offers pharmaceuticals (2, 3, 3N, 4), and related medical products. www.meritpharm.com or (800) 69-MERIT

Perfect Balance

Perfect Balance, Inc. is providing new hope for cancer victims. We have a proprietary formula which destroys the enzymatic protection of cancer cells and greatly increases NK cell activity. By inhibiting the production of Nagalase the cancer cell can no longer stop the immune system  from doing its job. Innate GC Maf resumes and rapid tumor breakdown is evident. Salicinium enhances NK cell activity and has been shown to kill
both Circulating Tumor Cells and Cancer Stem Cells.

Perfect Balance, Inc. has been in business for more than 25 years and has spent most of that time working in the field of cancer

AMARC Enterprises / POLY-MVA

Contributor, Sponsor and Supporter
San Diego, CA 92021
Phone (866) 765-9682 Toll Free or (619) 447-6500
Fax (619) 447-6501
solutions@meritpharm.com

AMARC Enterprises and Poly-MVA endeavor to treat people honestly and with integrity, and to promote healthy living through our search for the highest quality products. We seek to improve the health and quality of life through practitioners and patients in integrative and regenerative medicine. We know that through smart and targeted therapies with efficacious products people can live fuller, longer and happier lives. Since 2001, AMARC and PolyMVA have been providing quality, FDA compliant products that have helped thousands of people achieve better health.

Lipoic Acid Mineral Complex is the key component that makes Poly-MVA a uniquely-formulated supplement, containing a proprietary blend of the mineral palladium bonded to alpha-lipoic acid, Vitamins B1, B2 and B12, formyl-methionine, N-acetyl cysteine, plus trace amounts of molybdenum, rhodium, and ruthenium. Poly-MVA assists in boosting immune response by targeting key pathways with very specific nutrients and supports cellular metabolism. What makes Poly-MVA unique is the proprietary manufacturing process by which the mineral palladium is sequestered to lipoic acid and thiamin. No other company produces a product similar to Poly-MVA because of the preparation and bonding process through which LAMC is manufactured. The proprietary formulation of LAMC with other vitamins, minerals, and amino acids provides considerable targeted protection and mitochondrial support, helping to enable optimum functioning of multiple essential body systems.

Send in a test question for extra credit. We may add it to future exams!

Sorry. You must be logged in to view this form.